Company Search:
Advanced Search
Sponsored Links
ProPhase Labs Inc Company Snapshot
ProPhase Labs Inc operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares ProPhase Labs Inc with three other companies in this sector in UNITED STATES : China Pharma Holdings, Inc. (2019 sales of $10.92 million ), International Stem Cell Corporation ($9.47 million of which 79% was Biomedical market), and Albireo Pharma Inc ($9.64 million of which 100% was Pharmaceutical Indust).

Sales Analysis. ProPhase Labs Inc reported sales of $9.88 million for the year ending December of 2019. This represents a sharp decrease of 24.8% versus 2018, when the company's sales were $13.13 million.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
ProPhase Labs Inc
  Stock Performance Chart for ProPhase Labs Inc
  Stock Data: Recent Stock Performance:
  Current Price (7/31/2020): 1.71
(Figures in U.S. Dollars)
1 Week 3.0%   13 Weeks 22.1%  
4 Weeks 3.6%   52 Weeks -15.3%  
ProPhase Labs Inc Key Data:
  Ticker: PRPH Country: United States
  Exchanges: NAS BLN Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2019 Sales 9,876,000
(Year Ending Jan 2020).
Employees: 50
  Currency: U.S. Dollars Market Cap: 19,805,116
  Fiscal Yr Ends: December Shares Outstanding: 11,581,939
  Share Type: Common Closely Held Shares: 3,121,786
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.